Literature DB >> 1678274

The effect of pindolol on creatine kinase is not due to beta 2-adrenoceptor partial agonist activity.

N M Wheeldon, D M Newnham, G C Fraser, D G McDevitt, B J Lipworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1678274      PMCID： PMC1368590          DOI： 10.1111/j.1365-2125.1991.tb05603.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; L C McFarlane; W J Coutie; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  The application of theoretical goals based on biological variation data in proficiency testing.

Authors:  C G Fraser
Journal:  Arch Pathol Lab Med       Date:  1988-04       Impact factor: 5.534

3.  Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters.

Authors:  G M Costongs; P C Janson; B M Bas; J Hermans; J W van Wersch; P J Brombacher
Journal:  J Clin Chem Clin Biochem       Date:  1985-01

4.  Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.

Authors:  B Tomlinson; J M Cruickshank; Y Hayes; J C Renondin; J B Lui; B R Graham; A Jones; A D Lewis; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

5.  Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

Authors:  M J Brown; D C Brown; M B Murphy
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.